esreboxetine: Clinical Trials

5 trials of esreboxetine, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 1 enrolling by invitation, 1 recruiting, 1 withdrawn. 3 Phase 3, 1 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 33Enrolling by invitation 1, Recruiting 1, Withdrawn 1
Phase 11Completed 1
Phase 21Completed 1

Follow esreboxetine: new trials by email Literature Review of esreboxetine trials Research Report on esreboxetine

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Open-Label Safety Study of AXS-14 in Subjects With Fibromyalgia
AXS-14 (esreboxetine) - Fibromyalgia
Phase 3Enrolling by invitationAxsome Therapeutics, Inc.3002026-04-292026-11-06
Fibromyalgia Response With Esreboxetine Evaluated Using a Randomized Withdrawal Research Design
AXS-14 (Esreboxetine), Placebo - Fibromyalgia
Phase 3RecruitingAxsome Therapeutics, Inc.6202026-01-142026-11-10
Maintenance of Efficacy.
Esreboxetine, Placebo - Fibromyalgia
Phase 3WithdrawnPfizer2009-05-012018-11-29
Phase 1 Thorough QT (TQT) Study in Young Healthy Volunteers
esreboxetine, placebo, moxifloxacin - Fibromyalgia
Phase 1CompletedPfizer402008-12-012011-04-07
A Study To Assess Esreboxetine's Effect On Concentration, Memory, Decision Making And Problem Solving In Patients With Fibromyalgia.
Esreboxetine - Fibromyalgia
Phase 2CompletedPfizer892008-08-012018-12-04

Conditions studied

Fibromyalgia (5)  ·  Hyperalgesia (2)

Sponsors

Pfizer (3)  ·  Axsome Therapeutics, Inc. (2)

Countries

United States (3)  ·  Belgium (1)

NIH funding

2008 (1)